Vicore Pharma Holding AB
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q4 24 | Q1 25 | Q2 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|
| – | -9.4% | -9.9% | +24.8% | -11.6% | -13.7% | |
| – | -9.5% | -9.9% | +24.8% | -11.7% | -13.8% | |
| – | -38.1% | -50.9% | +64.4% | -34.7% | +13.6% | |
| – | – | – | – | – | – | |
| – | -4.8% | +8.2% | +80.5% | -29.9% | -11.7% | |
| – | -5.5% | +7.0% | +78.3% | -28.5% | -13.7% | |
| – | +23.9% | -20.9% | +34.5% | -13.6% | -41.3% | |
| – | -9.7% | -11.0% | +20.6% | -9.5% | -13.9% | |
| – | – | – | – | – | – | |
| – | +0.0% | +0.0% | +20.0% | +0.0% | +0.0% |
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.